Coro Global (CGLO) 10-Q 13 Dec 16 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2016	Nov. 10, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	Medefile International, Inc.
Entity Central Index Key	842,013
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Sep. 30, 2016
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,016
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		28,756,010

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Current assets
Cash	$ 2,584	$ 38,371
Accounts receivable		4,965
Merchant services reserve	2,938	2,938
Total assets	5,522	46,274
Current liabilities
Accounts payable and accrued liabilities	16,525	14,857
Note payable - related party	282,332
Convertible debenture - related party	16,868	15,681
Deferred revenues	154	439
Derivative liability	11,662	19,067
Total current liabilities	327,541	50,044
Stockholders' deficit
Preferred stock, $.0001 par value: 10,000,000 authorized, no shares issued and outstanding
Common stock, $.0001 par value: 700,000,000 authorized; 28,756,010 and 28,756,010 shares issued and outstanding on September 30, 2016 and December 31, 2015, respectively	2,875	2,875
Additional paid-in capital	28,504,754	28,504,754
Accumulated deficit	(28,829,648)	(28,511,399)
Total stockholders' deficit	(322,019)	(3,770)
Total liabilities and stockholders' deficit	$ 5,522	$ 46,274

Consolidated Balance Sheets (U3

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2016	Dec. 31, 2015
Statement Of Financial Position [Abstract]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	700,000,000	700,000,000
Common stock, shares issued	28,756,010	28,756,010
Common stock, shares outstanding	28,756,010	28,756,010

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Income Statement [Abstract]
Revenue	$ 9,608	$ 10,869	$ 25,101	$ 36,199
Cost of revenue
Cost of revenue		280		875
Gross profit	9,608	10,589	25,101	35,324
Operating expenses
Selling, general and administrative expenses	106,041	122,845	342,236	562,569
Depreciation and amortization expenses		22,148		66,447
Total operating expenses	106,041	144,993	342,236	629,016
Loss from operations	(96,433)	(134,404)	(317,135)	(593,692)
Other income (expenses)
Interest expense	(5,021)	(370)	(8,519)	(2,763)
Change in fair value of derivative liabilities	7,460	1,072	7,405	(1,907)
Total other income (expense)	2,439	702	(1,114)	(4,670)
Net loss	$ (93,994)	$ (133,702)	$ (318,249)	$ (598,362)
Net loss per share: basic and diluted	$ 0	$ 0	$ (0.01)	$ (0.03)
Weighted average share outstanding: basic and diluted	28,756,010	28,701,689	28,756,010	20,633,026

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities
Net income (loss)	$ (318,249)	$ (598,362)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization		66,447
Stock based compensation		111,000
Change in derivative liability	(7,405)	1,907
Changes in operating assets and liabilities
Accounts receivable	4,965	631
Inventory		875
Prepaid expense		5,709
Accounts payable and accrued liabilities	1,668	(29,447)
Accrued interest - convertible debenture	1,187	2,763
Accrued interest - note payable	7,332
Deferred revenue	(285)	(204)
Net cash used in operating activities	(310,787)	(438,681)
Cash flow from financing activities
Proceeds from note payable - related party	275,000
Payment on convertible note		(70,000)
Proceeds from common stock subscriptions		620,000
Net cash provided by financing activities	275,000	550,000
Net increase (decrease) in cash and cash equivalents	(35,787)	111,319
Cash and cash equivalents at beginning of period	38,371	36,170
Cash and cash equivalents at end of period	2,584	147,489
Supplemental disclosure of cash flow information
Cash paid for interest
Cash paid for income taxes
Noncash investing and financing activities
Stock issued for conversion of debt		$ 40,000

Basis of Presentation and Going

Basis of Presentation and Going Concern	9 Months Ended
	Sep. 30, 2016
Basis of presentation and going concern [Abstract]
BASIS OF PRESENTATION AND GOING CONCERN	1. BASIS OF PRESENTATION AND GOING CONCERN Basis of Presentation The accompanying unaudited consolidated financial statements of MedeFile International Inc., a Nevada corporation (the "Company"), have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete consolidated financial statements. These unaudited consolidated financial statements and related notes should be read in conjunction with the Company's Form 10-K for the fiscal year ended December 31, 2015. In the opinion of management, these unaudited consolidated financial statements reflect all adjustments that are of a normal recurring nature and which are necessary to present fairly the financial position of the Company as of September 30, 2016, and the results of operations and cash flows for the three and nine months ended September 30, 2016 and 2015. The results of operations for the three and nine months ended September 30, 2016 are not necessarily indicative of the results that may be expected for the entire fiscal year. Going Concern The accompanying financial statements have been prepared contemplating a continuation of the Company as a going concern. However, the Company has reported a net loss of $318,249 for the nine months ended September 30, 2016 and has negative working capital of $322,019 as of September 30, 2016. The accompanying financial statements have been prepared assuming the Company will continue as a going concern. The operating losses and working capital deficit raise substantial doubt about the Company's ability to continue as a going concern. The Company's ability to obtain additional financing depends on the success of its growth strategy and its future performance, each of which is subject to general economic, financial, competitive, legislative, regulatory, and other factors beyond the Company's control. We will need additional investments in order to continue operations. Additional investments are being sought, but we cannot guarantee that we will be able to obtain such investments. Financing transactions may include the issuance of equity or debt securities, obtaining credit facilities, or other financing mechanisms. However, the trading price of our common stock could make it more difficult to obtain financing through the issuance of equity or debt securities. Even if we are able to raise the funds required, we may incur unexpected costs and expenses, fail to collect significant amounts owed to us, or experience unexpected cash requirements that would force us to seek alternative financing. Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail our operations. Fair Value of Financial Instruments Cash and Equivalents, Deposits In-Transit, Receivables, Prepaid and Other Current Assets, Accounts Payable, Accrued Salaries and Wages and Other Current Liabilities The carrying amounts of these items approximated fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measures, Financial Accounting Standards Board (“FASB”) ASC Topic 820-10-35 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurements). Level 1 Level 2 Level 3 The application of the three levels of the fair value hierarchy under Topic 820-10-35 to our assets and liabilities as of September 30, 2016 and December 31, 2015 are described below: Fair Value Measurements Level 1 Level 2 Level 3 Total September 30, 2016: Liabilities Derivative Liabilities $ - $ - $ 11,662 $ 11,662 Total $ - $ - $ 11,662 $ 11,662 December 31, 2015: Liabilities Derivative Liabilities $ - $ - $ 19,067 $ 19,067 Total $ - $ - $ 19,067 $ 19,067 Derivative liability as of September 30, 2016 is $11,662, compared to $19,067 as of December 31, 2015.

Note Payable - Related Party

Note Payable - Related Party	9 Months Ended
	Sep. 30, 2016
Note Payable - Related Party [Abstract]
NOTE PAYABLE - RELATED PARTY	2. NOTE PAYABLE – RELATED PARTY During the nine months ended September 30, 2016, the Company entered into five unsecured 7% Promissory Notes with a significant shareholder. The notes mature four to twelve months from issuance and total $175,000. The changes in notes payable to related party consisted of the following during the nine months ended September 30, 2016: September 30, Notes payable – related party at beginning of period $ - Borrowings on notes payable – related party 175,000 Accumulated interest 5,855 Notes payable – related party at end of period $ 180,855 On July 15, 2016, the Company entered into an unsecured 7% Promissory Notes in the amount of $100,000 with a significant shareholder. The note has a one year term. The changes in notes payable consisted of the following during the nine months ended September 30, 2016: September 30, Notes payable at beginning of period $ - Borrowings on notes payable 100,000 Accumulated interest 1,477 Notes payable at end of period $ 101,477

Convertible Debenture - Related

Convertible Debenture - Related Party	9 Months Ended
	Sep. 30, 2016
Convertible Debenture - Related Party [Abstract]
CONVERTIBLE DEBENTURE - RELATED PARTY	3. CONVERTIBLE DEBEBTURE – RELATED PARTY The Company has entered into two 10% Secured Convertible Debentures with a significant shareholder, one in the amount of $50,000 on November 4, 2013 and the other in the amount of $60,000 on December 17, 2013. The debentures carry a one year term. Both debentures are convertible into common stock at a share price of the lower of $2.00 or 80% of the previous day’s closing price. During the year ended December 31, 2015, the lender converted $40,000 of the note principal and the Company made a payment of $70,000. The outstanding notes payable to related party consisted of the following as of September 30, 2016 and December 31, 2015: September 30, December 31, Convertible debenture – related party at beginning of period $ 15,681 122,538 Conversion - 40,000 Repayment - 70,000 Accumulated interest 1,187 3,143 Convertible debenture – related party at end of period $ 16,868 15,681

Derivative Liabilities

Derivative Liabilities	9 Months Ended
	Sep. 30, 2016
Derivative Liabilities [Abstract]
DERIVATIVE LIABILITIES	4. DERIVATIVE LIABILITIES In connection with certain securities purchase agreements entered into during the third quarter of 2011 and the second quarter of 2012, the Company granted warrants with ratchet provisions. The warrants expired four years from the date of grant. During the first two years of grant, if the Company were to issue additional shares of common stock at a price per share less than the exercise price in effect, the exercise price would be adjusted to equal the average price per share received by the Company for the additional shares issued. After the first two years following the issuance date, if the Company were to issue any additional shares of common stock at a price per share less than the exercise price in effect, the exercise price would be adjusted using a formula based on the existing exercise price, the outstanding shares before and after the issuance of such shares, and the average price during the issuance of such shares. In addition to the exercise price adjustment, the number of shares upon exercise of the warrants was also subject to adjustment. Upon grant, the Company assesses the fair value of the warrants using the Black Scholes pricing model and records a warrant liability for the value. The Company then assesses the fair value of the warrants quarterly based on the Black Scholes Model and increases or decreases the warrant liability to the new value, and records a corresponding gain or loss (see below for variables used in assessing the fair value). Due to the ratchet provisions, the Company treats the warrants as a derivative liability in accordance with the provisions of ASC 815 “Derivatives and Hedging” (ASC 815). ASC 815 applies to any freestanding financial instruments or embedded features that have the characteristics of a derivative and to any freestanding financial instruments that potentially settle in an entity’s own common stock. Transactions involving warrants with ratchet provisions during the nine months ended September 30, 2016 are as follows: All remaining warrants have expired. Number of Warrants Weighted-Average Price Per Share Outstanding at December 31, 2015 60,000 $ 10 Granted - - Exercised - - Canceled or expired 60,000 10 Addition due to ratchet trigger - - Outstanding at September 30, 2016 - $ 0- The change in fair value of the warrant derivative liability consisted of the following during the nine months ended September 30, 2016: September 30, Warrant liability (beginning fair value) $ 1,271 Additional liability due to new grants - Loss (gain) on changes in fair market value of warrant liability (1,271 ) Warrant liability (ending fair value) $ - Change in fair market value of warrant liability resulted in a gain of $1,271 for the nine months ended September 30, 2016. The Company entered into two 10% Secured Convertible Debentures with a significant shareholder, one in the amount of $50,000 on November 4, 2013 and the other in the amount of $60,000 on December 17, 2013. The debentures carry a one year term. The Debentures are convertible into common stock at a share price of the lower of $2.00 or 80% of the previous day’s closing price. The Company assesses the fair value of the convertible debenture using the Black Scholes pricing model and records a derivative liability for the value. The Company then assesses the fair value of the warrants quarterly based on the Black Scholes Model and increases or decreases the liability to the new value, and records a corresponding gain or loss (see below for variables used in assessing the fair value). Due to the variable conversion rates, the Company treats the convertible debenture as a derivative liability in accordance with the provisions of ASC 815 “Derivatives and Hedging” (ASC 815). ASC 815 applies to any freestanding financial instruments or embedded features that have the characteristics of a derivative and to any freestanding financial instruments that potentially settle in an entity’s own common stock. The fair value of the conversion options was determined using the Black-Scholes Option Pricing Model and the following significant assumptions during the nine months ended September 30, 2016: September 30, Risk-free interest rate .45 % Expected stock price volatility 196 % Expected dividend payout - Expected option in life-years .25 The change in fair value of the conversion option derivative liability consisted of the following during the nine months ended September 30, 2016: September 30, Conversion option liability (beginning fair value) $ 17,796 Additional liability due to new grants - Loss (gain) on changes in fair market value of derivative liability (6,134 ) Conversion option liability (ending fair value) $ 11,662 Change in fair market value of conversion option liability resulted in a gain of $6,134 for the nine months ended September 30, 2016.

Subsequent Event

Subsequent Event	9 Months Ended
	Sep. 30, 2016
Subsequent Event [Abstract]
SUBSEQUENT EVENT	6. SUBSEQUENT EVENT On October 27, 2016 the Company entered into an additional 7% Promissory Note with a significant shareholder in the amount of $12,000. The note has a six month term.

Basis of Presentation and Goi11

Basis of Presentation and Going Concern (Policies)	9 Months Ended
	Sep. 30, 2016
Basis of presentation and going concern [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited consolidated financial statements of MedeFile International Inc., a Nevada corporation (the "Company"), have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete consolidated financial statements. These unaudited consolidated financial statements and related notes should be read in conjunction with the Company's Form 10-K for the fiscal year ended December 31, 2015. In the opinion of management, these unaudited consolidated financial statements reflect all adjustments that are of a normal recurring nature and which are necessary to present fairly the financial position of the Company as of September 30, 2016, and the results of operations and cash flows for the three and nine months ended September 30, 2016 and 2015. The results of operations for the three and nine months ended September 30, 2016 are not necessarily indicative of the results that may be expected for the entire fiscal year.
Going Concern	Going Concern The accompanying financial statements have been prepared contemplating a continuation of the Company as a going concern. However, the Company has reported a net loss of $318,249 for the nine months ended September 30, 2016 and has negative working capital of $322,019 as of September 30, 2016. The accompanying financial statements have been prepared assuming the Company will continue as a going concern. The operating losses and working capital deficit raise substantial doubt about the Company's ability to continue as a going concern. The Company's ability to obtain additional financing depends on the success of its growth strategy and its future performance, each of which is subject to general economic, financial, competitive, legislative, regulatory, and other factors beyond the Company's control. We will need additional investments in order to continue operations. Additional investments are being sought, but we cannot guarantee that we will be able to obtain such investments. Financing transactions may include the issuance of equity or debt securities, obtaining credit facilities, or other financing mechanisms. However, the trading price of our common stock could make it more difficult to obtain financing through the issuance of equity or debt securities. Even if we are able to raise the funds required, we may incur unexpected costs and expenses, fail to collect significant amounts owed to us, or experience unexpected cash requirements that would force us to seek alternative financing. Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail our operations.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Cash and Equivalents, Deposits In-Transit, Receivables, Prepaid and Other Current Assets, Accounts Payable, Accrued Salaries and Wages and Other Current Liabilities The carrying amounts of these items approximated fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measures, Financial Accounting Standards Board (“FASB”) ASC Topic 820-10-35 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurements). Level 1 Level 2 Level 3 The application of the three levels of the fair value hierarchy under Topic 820-10-35 to our assets and liabilities as of September 30, 2016 and December 31, 2015 are described below: Fair Value Measurements Level 1 Level 2 Level 3 Total September 30, 2016: Liabilities Derivative Liabilities $ - $ - $ 11,662 $ 11,662 Total $ - $ - $ 11,662 $ 11,662 December 31, 2015: Liabilities Derivative Liabilities $ - $ - $ 19,067 $ 19,067 Total $ - $ - $ 19,067 $ 19,067 Derivative liability as of September 30, 2016 is $11,662, compared to $19,067 as of December 31, 2015.

Basis of Presentation and Goi12

Basis of Presentation and Going Concern (Tables)	9 Months Ended
	Sep. 30, 2016
Basis of presentation and going concern [Abstract]
Schedule of three levels of the fair value hierarchy to assets and liabilities	Fair Value Measurements Level 1 Level 2 Level 3 Total September 30, 2016: Liabilities Derivative Liabilities $ - $ - $ 11,662 $ 11,662 Total $ - $ - $ 11,662 $ 11,662 December 31, 2015: Liabilities Derivative Liabilities $ - $ - $ 19,067 $ 19,067 Total $ - $ - $ 19,067 $ 19,067

Note Payable - Related Party (T

Note Payable - Related Party (Tables)	9 Months Ended
	Sep. 30, 2016
Note Payable - Related Party [Abstract]
Summary of changes in notes payable - related party	September 30, Notes payable – related party at beginning of period $ - Borrowings on notes payable – related party 175,000 Accumulated interest 5,855 Notes payable – related party at end of period $ 180,855
Summary of changes in notes payable	September 30, Notes payable at beginning of period $ - Borrowings on notes payable 100,000 Accumulated interest 1,477 Notes payable at end of period $ 101,477

Convertible Debenture - Relat14

Convertible Debenture - Related Party (Tables)	9 Months Ended
	Sep. 30, 2016
Convertible Debenture - Related Party [Abstract]
Schedule of convertible debentures - related party	September 30, December 31, Convertible debenture – related party at beginning of period $ 15,681 122,538 Conversion - 40,000 Repayment - 70,000 Accumulated interest 1,187 3,143 Convertible debenture – related party at end of period $ 16,868 15,681

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	9 Months Ended
	Sep. 30, 2016
Derivative Liabilities [Abstract]
Schedule of transactions involving warrants	Number of Warrants Weighted-Average Price Per Share Outstanding at December 31, 2015 60,000 $ 10 Granted - - Exercised - - Canceled or expired 60,000 10 Addition due to ratchet trigger - - Outstanding at September 30, 2016 - $ 0-
Schedule of change in fair value of the warrant derivative liability	September 30, Warrant liability (beginning fair value) $ 1,271 Additional liability due to new grants - Loss (gain) on changes in fair market value of warrant liability (1,271 ) Warrant liability (ending fair value) $ -
Schedule of embedded features of derivative financial instruments	September 30, Risk-free interest rate .45 % Expected stock price volatility 196 % Expected dividend payout - Expected option in life-years .25
Schedule of change in fair value of the conversion option derivative liability	September 30, Conversion option liability (beginning fair value) $ 17,796 Additional liability due to new grants - Loss (gain) on changes in fair market value of derivative liability (6,134 ) Conversion option liability (ending fair value) $ 11,662

Basis of Presentation and Goi16

Basis of Presentation and Going Concern (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Liabilities
Derivative Liabilities	$ 11,662	$ 19,067
Total	11,662	19,067
Level 1
Liabilities
Derivative Liabilities
Total
Level 2
Liabilities
Derivative Liabilities
Total
Level 3
Liabilities
Derivative Liabilities	11,662	19,067
Total	$ 11,662	$ 19,067

Basis of Presentation and Goi17

Basis of Presentation and Going Concern (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Basis of Presentation and Going Concern (Textual)
Net income (loss)	$ (93,994)	$ (133,702)	$ (318,249)	$ (598,362)
Negative working capital			322,019
Derivative liability			$ 11,662		$ 19,067

Note Payable - Related Party (D

Note Payable - Related Party (Details) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Class Of Warrant Or Right [Line Items]
Notes payable - related party at beginning of period
Borrowings on notes payable - related party	275,000
Notes payable - related party [Member]
Class Of Warrant Or Right [Line Items]
Notes payable - related party at beginning of period
Borrowings on notes payable - related party	175,000
Accumulated interest	5,855
Notes payable at end of period	$ 180,855

Note Payable - Related Party 19

Note Payable - Related Party (Details 1) - Notes payable [Member]	9 Months Ended
	Sep. 30, 2016USD ($)
Short-term Debt [Line Items]
Notes payable at beginning of period
Borrowings on notes payable	100,000
Accumulated Interest	1,477
Notes payable at end of period	$ 101,477

Note Payable - Related Party 20

Note Payable - Related Party (Details Textual) - Unsecured Promissory Notes [Member]	Jul. 15, 2016USD ($)	Sep. 30, 2016USD ($)PromissoryNotes
Notes Payable - Related Party (Textual)
Number of unsecured promissory notes | PromissoryNotes		5
Unsecured promissory notes interest rate	7.00%	7.00%
Term of note payable	1 year
Term of note payable, description		The notes mature four to twelve months.
Principal amount | $	$ 100,000	$ 175,000

Convertible Debenture - Relat21

Convertible Debenture - Related Party (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Convertible Debenture - Related Party [Abstract]
Convertible debenture - related party at beginning of period	$ 15,681	$ 122,538
Conversion		40,000
Repayment		70,000
Accumulated interest	1,187	3,143
Convertible debenture - related party at end of period	$ 16,868	$ 15,681

Convertible Debenture - Relat22

Convertible Debenture - Related Party (Details Textual)	Dec. 17, 2013USD ($)Debenture	Nov. 04, 2013USD ($)Debenture	Sep. 30, 2016USD ($)	Dec. 31, 2015USD ($)
Convertible Debenture - Related Party (Textual)
Conversion note principal amount				$ 40,000
Covertible debenture repayment				$ 70,000
Convertible Debt Securities [Member]
Convertible Debenture - Related Party (Textual)
Convertible debenture issued	$ 60,000	$ 50,000
Secured convertible debentures interest rate	10.00%	10.00%
Number of secured convertible debentures | Debenture	1	1
Term on secured convertible debentures	1 year	1 year
Conversion of feature description			Both debentures are convertible into common stock at a share price of the lower of $2.00 or 80% of the previous day's closing price.

Derivative Liabilities (Details

Derivative Liabilities (Details) - Warrants with ratchet provisions [Member]	9 Months Ended
	Sep. 30, 2016$ / sharesshares
Number of Warrants
Beginning Balance | shares	60,000
Granted | shares
Exercised | shares
Canceled or expired | shares	60,000
Additional due to ratchet trigger | shares
Ending Balance | shares
Weighted-Average Price Per Share
Beginning Balance | $ / shares	$ 10
Granted | $ / shares
Exercised | $ / shares
Canceled or expired | $ / shares	10
Addition due to ratchet trigger | $ / shares
Ending Balance | $ / shares	$ 0

Derivative Liabilities (Detai24

Derivative Liabilities (Details 1) - Warrant derivative liabilities [Member]	9 Months Ended
	Sep. 30, 2016USD ($)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Warrant liability (beginning fair value)	$ 1,271
Additional liability due to new grants
Loss(gain) on changes in fair market value of warrant liability	(1,271)
Warrant liability (ending fair value)

Derivative Liabilities (Detai25

Derivative Liabilities (Details 2)	9 Months Ended
	Sep. 30, 2016
Derivative Liabilities [Abstract]
Risk-free interest rate	0.45%
Expected stock price volatility	196.00%
Expected dividend payout
Expected option in life-years	3 months

Derivative Liabilities (Detai26

Derivative Liabilities (Details 3)	9 Months Ended
	Sep. 30, 2016USD ($)
Class Of Warrant Or Right [Line Items]
Conversion option liability (beginning fair value)	$ 19,067
Conversion option liability (ending fair value)	11,662
Convertible debenture [Member]
Class Of Warrant Or Right [Line Items]
Conversion option liability (beginning fair value)	17,796
Additional liability due to new grants
Loss (gain) on changes in fair market value of derivative liability	(6,134)
Conversion option liability (ending fair value)	$ 11,662

Derivative Liabilities (Detai27

Derivative Liabilities (Details Textual)	Dec. 17, 2013USD ($)Debenture	Nov. 04, 2013USD ($)Debenture	Sep. 30, 2016USD ($)
Convertible Debt [Member]
Class of Warrant or Right [Line Items]
Change in fair market value			$ (6,134)
Warrant derivative liabilities [Member]
Class of Warrant or Right [Line Items]
Change in fair market value			$ (1,271)
Convertible Debt Securities [Member]
Class of Warrant or Right [Line Items]
Number of secured convertible debentures | Debenture	1	1
Convertible debenture issued	$ 60,000	$ 50,000
Secured convertible debentures interest rate	10.00%	10.00%
Debt instrument term	1 year	1 year
Conversion of feature description			Both debentures are convertible into common stock at a share price of the lower of $2.00 or 80% of the previous day's closing price.

Subsequent Event (Details)

Subsequent Event (Details) - Subsequent Event [Member]	Oct. 27, 2016USD ($)
Subsequent Event [Line Items]
Percentage of promissory note	7.00%
Promissory note	$ 12,000
Debt instrument term	6 months